Back to the main directory
Press Release
- Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO by GlobeNewsWire
- Mobivity's Connected Rewards Gains Significant Momentum with Convenience Store Retailers in Q4, Expanding National Reach by GlobeNewsWire
- Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced Melanoma by GlobeNewsWire
- InnovAge Celebrates 35 Years of Transforming Senior Care by GlobeNewsWire
- Spectral AI Highlights Unprecedented Collaboration with National Leaders in Burn Care for DeepView™ System Training and Validation Studies by GlobeNewsWire
- Absci Highlights Progress and Updates Across Proprietary Pipeline and Leading AI Platform at 2024 R&D Day by GlobeNewsWire
- SHARC Energy Announces Michael Albertson as New CEO, President and Director by GlobeNewsWire
- ALPHAMIN ANNOUNCES AWARD OF STOCK OPTIONS AND SAR EQUIVALENT SHARES by GlobeNewsWire
- PubMatic y GroupM amplían su colaboración para potenciar el impacto en el mercado de LATAM by GlobeNewsWire
- Star Group Announces Definitive Acquisition Agreement by GlobeNewsWire
- EQS-News: New York Life Investments and its European Affiliate, Candriam, Announce Strategic Partnership with Andera Partners by EQS Group AG
- Tudor Gold Corp. Retains Outside Counsel to Dispute the Seabridge Gold Inc. (KSM Mining ULC) Licence of Occupation and Other Mitchell Treaty Creek Tunnel Permits by Newsfile Corp.
- EQS-News: Multitude Group financial calendar for 2025 by EQS Group AG
- GE HealthCare to announce fourth quarter and full year 2024 results on February 13, 2025 by BusinessWire
- Redfin Reports Homebuying Demand Sitting Near Highest Level Since Early Spring As Mortgage Rates Fall by BusinessWire
- Alzamend Neuro Reports Second Quarter 2025 Financial Results and Provides Update on Clinical Programs by BusinessWire
- Intuit QuickBooks and the Professional Women’s Hockey League Announce Multi-year Canadian Partnership by BusinessWire
- Atossa Therapeutics to Present Poster Describing the Discovery of Molecules Synergistic with (Z)-endoxifen for the Treatment of Breast Cancer at the 2024 San Antonio Breast Cancer Symposium by GlobeNewsWire
- Pfizer’s IBRANCE® in Combination with Standard-of-Care Therapies Extends Median Progression-Free Survival by Over 15 Months in Phase 3 PATINA Study in Patients with HR+, HER2+ Metastatic Breast Cancer by BusinessWire
- Scilex Holding Company Announces $17 Million Registered Direct Offering by GlobeNewsWire
- Intevac Provides Cash and Revenue Guidance, Announces Dividend, Further Restructuring to Strengthen Profitability, and Investigation of Strategic Options by BusinessWire
- Illinois’ McHenry County State’s Attorney’s Office Embraces Digital Transformation with NICE Justice AI-Powered Evidence Management by BusinessWire
- Man Group PLC : Form 8.3 - Direct Line Insurance Group plc by GlobeNewsWire
- Man Group PLC : Form 8.3 - Spirent Communications plc by GlobeNewsWire
- SEALSQ Brings Quantum Technology to Drone and UAV Markets by GlobeNewsWire